Tresiba 100 units/mL (U-100) single-patient-use FlexTouch Pen Images
Generic Name: insulin degludec
This medication has been identified as Tresiba 100 units/mL (U-100) single-patient-use FlexTouch Pen. It is supplied by Novo Nordisk.
Tresiba is used in the treatment of Diabetes, Type 2; Diabetes, Type 1; Diabetes Mellitus and belongs to the drug class insulin. Risk cannot be ruled out during pregnancy. Tresiba 100 units/mL (U-100) single-patient-use FlexTouch Pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Tresiba
- Generic Name
- insulin degludec
- Strength
- 100 units/mL (U-100) single-patient-use FlexTouch Pen
- Availability
- Prescription only
- Drug Class
- Insulin
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-2660
More about Tresiba (insulin degludec)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (150)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: insulin
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
